A Study of RO4989991 in Patients With Allergic Rhinitis

NCT01152619 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Placebo
DRUG: RO4989991

Sponsor

Hoffmann-La Roche